Polycyclic aromatic hydrocarbons (PAH) such as dibenzo[a,l]pyrene (DBP) are wide-spread environmental pollutants most probably mutagenic and carcinogenic to humans. Detailed data on the cytogenetic effects of anti-11,12-dihydroxy-13,14-epoxy-11,12,13,14-tetrahydrodibenzo[a,l]pyrene (DBPDE) in mammalian cells are not available in the literature. The aim of this study is to elucidate the mechanisms involved in the induction of chromosomal aberrations and sister chromatid exchanges (SCEs) by DBPDE in mammalian cells. In order to achieve this a parental (AA8) and different DNA repair-deficient Chinese hamster ovary cell lines such as UV4, UV5, UV61 (nucleotide excision repair, NER), EM9 (base excision repair, BER), irs1SF (homologous recombination repair, HRR) and V3-3 (non-homologous end joining, NHEJ) were used. The most sensitive cell lines for DBPDE-induced chromosome aberrations were EM9 and irs1SF, while EM9 and V3-3 cell lines were the most sensitive in terms of SCEs induction. It can be suggested that the BER pathway plays an important role in the repair of lesions induced by DBPDE, affecting both chromosomal aberrations and SCEs induction. Moreover, the HRR pathway seems to play a role in cellular resistance to DBPDE mainly in terms of chromosomal aberration induction while the NHEJ pathway takes part affecting only the induction of SCEs.

1.
Bender MA, Griggs HG, Bedford JS: Mechanisms of chromosomal aberration production III. Chemicals and ionising radiations. Mutat Res 23:197–212 (1974).
2.
Braithwaite E, Wu X, Wang Z: Repair of DNA lesions: mechanisms and relative repair efficiencies. Mutat Res 8:424 207–219 (1999).
3.
Buterin T, Hess MT, Luneva N, Geacintov NE, Amin S, et al: Unrepaired fjord region polycyclic aromatic hydrocarbon-DNA adducts in ras codon 61 mutational hot spots. Cancer Res 60:1849–56 (2000).
4.
Dipple A: Polycyclic aromatic hydrocarbons: an introduction, in Harvey RG (ed): Polycyclic Hydrocarbons and Carcinogenesis, ACS Symposium Series 283, pp 1–17 (American Chemical Society, Washington DC, 1985).
5.
Dipple A, Pigott MA, Agarwal SK, Yagi H, Sayer JM, Jerina DM: Optically active benzo[c]phenanthrene diol epoxides bind extensively to adenine in DNA. Nature 327:535–536 (1987).
6.
Dreij K, Seidel A, Jernstrom B: Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells. Chem Res Toxicol 18:655–664 (2005).
7.
Geacintov NE, Broyde S, Buterin T, Naegeli H, Wu M, et al: Thermodynamic and structural factors in the removal of bulky DNA adducts by the nucleotide excision repair machinery. Biopolymers 65:202–210 (2002).
8.
IARC: Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, in IARC (ed): Tobacco Smoking 38 (Lyon, France, 1986).
9.
Jankowiak R, Ariese F, Hewer A, Luch A, Zamzow D, et al: Structure, conformations, and repair of DNA adducts from dibenzo[a, l]pyrene: 32P-postlabeling and fluorescence studies. Chem Res Toxicol 11:674–685 (1998).
10.
Lagerqvist A, Hakansson D, Prochazka G, Lundin C, Dreij K, et al: Both replication bypass fidelity and repair efficiency influence the yield of mutations per target dose in intact mammalian cells induced by benzo[a]pyrene-diol-epoxide and dibenzo[a[,]l]pyrene-diol-epoxide. DNA Repair 7:1202–1212 (2008).
11.
Lindahl T, Wood RD: Quality control by DNA repair. Science 286:1897–1905 (1999).
12.
Meschini R, Marotta E, Berni A, Filippi S, Fiore M, et al: DNA repair deficiency and BPDE-induced chromosomal alterations in CHO cells. Mutat Res 637:93–100 (2008).
13.
Natarajan AT, Tates AD, Meijers M, Neuteboom I, de Vogel N: Induction of sister-chromatid exchanges (SCEs) and chromosomal aberrations by mitomycin C and methyl methanesulfonate in Chinese hamster ovary cells. An evaluation of methodology for detection of SCEs and of persistent DNA lesions towards the frequencies of observed SCEs. Mutat Res 121:211–223 (1983).
14.
Paajarvi G, Jernstrom B, Seidel A, Stenius U: Anti-diol epoxide of benzo[a]pyrene induces transient Mdm2 and p53 Ser15 phosphorylation, while anti-diol epoxide of dibenzo[a,l]pyrene induces a nontransient p53 ser15 phosphorylation. Mol Carcinog 47:301–309 (2008).
15.
Palitti F, Becchetti A: Effect of caffeine on sister chromatid exchanges and chromosomal aberrations induced by mutagens in Chinese hamster cells. Mutat Res 45:157–159 (1977).
16.
Perry P, Wolff S: New Giemsa method for differential staining of sister chromatids. Nature 251:156–158 (1974).
17.
Ralston SL, Seidel A, Luch A, Platt KL, Baird WM: Stereo-selective activation of dibenzo[a,l]pyrene to (-)-anti-(11R,12S,13S,14R)- and (+)-syn-(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7. Carcinogenesis 16:2899–2907 (1995).
18.
Rouse J, Jackson SP: Interfaces between the detection, signalling, and repair of DNA damage. Science 297:547–551 (2002).
19.
Sims P, Grover PL: Epoxides in polycyclic aromatic hydrocarbon metabolism and carcinogenesis. Adv Cancer Res 20:165–274 (1974).
20.
Thakker DR, Yagi H, Levin W, Wood AW, Conney AH, Jerina DM: Polycyclic aromatic hydrocarbons: Metabolic activation to ultimate carcinogens, in Anders MW (ed): Bioactivation of Foreign Compounds, pp 177–242. (Academic Press, London 1985).
21.
Thompson LH, Brookman KW, Dillehay LE, Carrano AV, Mazrimas JA, et al: A CHO-cell strain having hypersensitivity to mutagens, a defect in DNA strand-break repair, and an extraordinary baseline frequency of sister-chromatid exchange. Mutat Res 95:427–440 (1982).
22.
Zhou BB, Elledge SJ: The DNA damage response: putting checkpoints in perspective. Nature 408:433–439 (2000).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.